Evidence map›Paper›PMID 28058511›Full record

ArticleNeurogenetics2017

Identification and functional characterization of a novel MTFMT mutation associated with selective vulnerability of the visual pathway and a mild neurological phenotype.

Roberta La Piana, Woranontee Weraarpachai, Luis H Ospina, Martine Tetreault, Jacek Majewski, Care4Rare Canada Consortium, G Bruce Pike, Jean-Claude Decarie, Donatella Tampieri, Bernard Brais and 1 more

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Neurogenetics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Mitochondrial methionylThe Journal of biological chemistry · 2018
    Article
  7. Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Roberta La PianaLaboratory of Neurogenetics of Motion, Montreal Neurological Institute and Hospital, McGill University, Montreal, QC, Canada.
Woranontee WeraarpachaiDepartment of Human Genetics, Montreal Neurological Institute, McGill University, Montreal, QC, Canada.
Luis H OspinaDepartment of Ophthalmology, Centre Hospitalier Universitaire Sainte-Justine, Université de Montréal, Montreal, QC, Canada.
Martine TetreaultDepartment of Human Genetics, McGill University, Genome Québec Innovation Center, Montreal, QC, Canada.
Jacek MajewskiDepartment of Human Genetics, McGill University, Genome Québec Innovation Center, Montreal, QC, Canada.
Care4Rare Canada Consortium
G Bruce PikeDepartments of Radiology and Clinical Neurosciences, Hotchkiss Brain Institute, University of Calgary, Calgary, AB, Canada.
Jean-Claude DecarieDepartment of Radiology, Radiotherapy and Nuclear Medicine, Université de Montréal, Montréal, Québec, Canada.
Donatella TampieriDepartment of Neuroradiology, Montreal Neurological Institute and Hospital, McGill University, Montreal, QC, Canada.
Bernard BraisLaboratory of Neurogenetics of Motion, Montreal Neurological Institute and Hospital, McGill University, Montreal, QC, Canada.
Eric A ShoubridgeDepartment of Human Genetics, Montreal Neurological Institute, McGill University, Montreal, QC, Canada. eric@ericpc.mni.mcgill.ca.
McGill University · CAMontreal Neurological Institute and Hospital · CAUniversité de Montréal · CAUniversity of Calgary · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mitochondrial protein synthesis is initiated by formylated tRNA-methionine, which requires the activity of MTFMT, a methionyl-tRNA formyltransferase. Mutations in MTFMT have been associated with Leigh syndrome, early-onset mitochondrial leukoencephalopathy, microcephaly, ataxia, and cardiomyopathy. We identified compound heterozygous MTFMT mutations in a patient with a mild neurological phenotype and late-onset progressive visual impairment. MRI studies documented a progressive and selective involvement of the retrochiasmatic visual pathway. MTFMT was undetectable by immunoblot analysis of patient fibroblasts, resulting in specific defects in mitochondrial protein synthesis and assembly of the oxidative phosphorylation complexes. This report expands the clinical and MRI phenotypes associated with MTFMT mutations, illustrating the complexity of genotype-phenotype relationships in mitochondrial translation disorders.

Indexed as

Cognitive DysfunctionDNA Mutational AnalysisFemaleHumansHydroxymethyl and Formyl TransferasesMitochondrial DiseasesPhenotypeVision DisordersVisual PathwaysYoung AdultHydroxymethyl and Formyl Transferasesmethionyl-tRNA formyltransferaseLeukoencephalopathyMTFMTOptic pathwayOXPHOS defectsWhole exome sequencing

Identifiers

PMID28058511
OpenAlexW2568135830

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.